Clinical Trials Browser

Phase 2 × Metformin × Plasma cell × Clear all

NCT04850846 2026-02-09

Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma

Phase 2 Active not recruiting

60 enrolled 10 charts

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance